News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CHEMICON International, Inc. (SERO) Enters Into License Agreement With RheoGene, Inc.


11/28/2005 1:19:36 PM

ATLANTA--(BUSINESS WIRE)--Nov. 28, 2005--Serologicals Corporation (NASDAQ: SERO) announced today that Chemicon International, Inc., its wholly-owned subsidiary based in Temecula, CA, and RheoGene, Inc. (Norristown, PA) have signed a semi-exclusive license to use RheoGene's RheoSwitch(R) System and related technologies within Chemicon's research product lines focused on specialty research markets, including Chemicon's growing stem cell biology portfolio of products.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES